# SILDENAFIL CITRATE
> **ANDA204882** · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2018-06-11
## Drug
- **FDA Application Number:** ANDA204882
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SILDENAFIL CITRATE
- **Generic name:** SILDENAFIL
- **Active ingredients:** SILDENAFIL CITRATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** RUBICON RESEARCH
- **Manufacturer:** Advagen Pharma Ltd
- **First approval:** 2018-06-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204882)
---
*MORVS · CC0 1.0*